» Journals » Adv Drug Deliv Rev

Advanced Drug Delivery Reviews

Advanced Drug Delivery Reviews is a highly regarded scientific journal that publishes cutting-edge research and critical reviews in the field of drug delivery systems. It covers a wide range of topics, including nanotechnology, biomaterials, targeted therapies, and controlled release systems, providing valuable insights into the development and optimization of drug delivery strategies for enhanced therapeutic outcomes.

Details
Abbr. Adv Drug Deliv Rev
Start 1987
End Continuing
Frequency Twelve no. a year, 2001-
p-ISSN 0169-409X
e-ISSN 1872-8294
Country Netherlands
Language English
Specialty Pharmacology
Metrics
h-index / Ranks: 104 366
SJR / Ranks: 473 3411
CiteScore / Ranks: 252 23.30
JIF / Ranks: 203 16.1
Recent Articles
1.
2.
Xu T, Rao J, Mo Y, Lam A, Yang Y, Wong S, et al.
Adv Drug Deliv Rev . 2025 Mar; 219:115552. PMID: 40032068
The musculoskeletal system relies on critical tissue interfaces for its function; however, these interfaces are often compromised by injuries and diseases. Restoration of these interfaces is complex by nature which...
3.
Hasegawa M, Kijima S
Adv Drug Deliv Rev . 2025 Mar; 220:115553. PMID: 40024482
In Japan, there has been a growing adoption of Model Informed Drug Development (MIDD) approaches as the rationale for optimal dose decision and modeling outputs have supported better characterizing the...
4.
Belyaev I, Griaznova O, Yaremenko A, Deyev S, Zelepukin I
Adv Drug Deliv Rev . 2025 Feb; 219:115550. PMID: 40021012
Delivery of nanoparticles (NPs) to solid tumors has long relied on enhanced permeability and retention (EPR) effect, involving permeation of NPs through a leaky vasculature with prolonged retention by reduced...
5.
Guerassimoff L, De Smedt S, Sauvage F, Baudoin M
Adv Drug Deliv Rev . 2025 Feb; 220:115551. PMID: 39988259
Acoustic tweezers are a highly promising technology for targeted drug delivery thanks to their unique capabilities: (i) they can effectively operate in both in vitro and in vivo environments, (ii)...
6.
Banstola A, Lin Z, Li Y, Wu M
Adv Drug Deliv Rev . 2025 Feb; 219:115549. PMID: 39986440
Light, a non-invasive tool integrated with cutting-edge nanotechnologies, has driven transformative advancements in imaging-based diagnosis and drug delivery for cancer and bacterial treatments. This review discusses recent progress in these...
7.
Wang R, Wang Z, Zhang M, Zhong D, Zhou M
Adv Drug Deliv Rev . 2025 Feb; 219:115519. PMID: 39955076
Microalgae present a novel and multifaceted approach to cancer therapy by modulating the tumor-associated microbiome (TAM) and the tumor microenvironment (TME). Through their ability to restore gut microbiota balance, reduce...
8.
Orr A, Kalantarnia F, Nazir S, Bolandi B, Alderson D, OGrady K, et al.
Adv Drug Deliv Rev . 2025 Feb; 218:115524. PMID: 39900293
The design of neural tissue models with architectural and biochemical relevance to native tissues opens the way for the fundamental study and development of therapies for many disorders with limited...
9.
Izrael M, Chebath J, Molakandov K, Revel M
Adv Drug Deliv Rev . 2025 Jan; 218:115525. PMID: 39880333
Self-renewal capacity and potential to differentiate into almost any cell type of the human body makes pluripotent stem cells a valuable starting material for manufacturing of clinical grade cell therapies....
10.
Kwokdinata C, Chew S
Adv Drug Deliv Rev . 2025 Jan; 218:115523. PMID: 39880332
Combinatorial treatments integrating cells and biomolecules within scaffolds have been investigated to address the multifactorial nature of spinal cord injury (SCI). Current regenerative treatments have been ineffective as they do...